The Joint Clinical Assessment (JCA) framework took effect on 12th January 2025, and its impact is top of mind among pharma innovators today. The policy was the buzz of the International Society for ...
The complex and changing needs of patients with life-threatening conditions has led many health authorities to introduce early access programmes. These pathways offer patients who have severe ...